Evidence map›Paper›PMID 32589949›Full record

ArticleChest2020

Association of Palliative Care Use and Setting With Health-care Utilization and Quality of Care at the End of Life Among Patients With Advanced Lung Cancer.

Kelly C Vranas, Jodi A Lapidus, Linda Ganzini, Christopher G Slatore, Donald R Sullivan

Open access · greenAbstract read
In one paragraph

Article in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Predicting the Future by Studying the Past for Patients With Cancer Diagnosed in the Emergency Department.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Quality of life in terminally ill cancer patients: what is the role of using complementary and alternative medicines?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kelly C VranasDivision of Pulmonary and Critical Care, Oregon Health & Science University, Portland, OR; Health Services Research & Development, VA Portland Health Care System, Portland, OR; Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania, Philadelphia, PA; Section of Pulmonary and Critical Care Medicine, Veterans Affairs Portland Health Care System, Portland, OR. Electronic address: vranas@ohsu.edu.
Jodi A LapidusDepartment of Biostatistics, School of Public Health, Oregon Health & Science University, Portland, OR.
Linda GanziniHealth Services Research & Development, VA Portland Health Care System, Portland, OR; Department of Psychiatry, Oregon Health & Science University, Portland, OR.
Christopher G SlatoreDivision of Pulmonary and Critical Care, Oregon Health & Science University, Portland, OR; Health Services Research & Development, VA Portland Health Care System, Portland, OR; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Section of Pulmonary and Critical Care Medicine, Veterans Affairs Portland Health Care System, Portland, OR.
Donald R SullivanDivision of Pulmonary and Critical Care, Oregon Health & Science University, Portland, OR; Health Services Research & Development, VA Portland Health Care System, Portland, OR; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
Oregon Health & Science University · USVA Portland Health Care System · USHealth Services Research & Development · US

Funding

Oregon Emergency Care Research Multidisciplinary Training ProgramK12HL133115 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORRIS, CYNTHIA D, NEWGARD, CRAIG D. · 2016 to 2020
$2.9M
Impact of Specialist Palliative Care on Outcomes in Advanced Stage Lung CancerK07CA190706 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI SULLIVAN, DONALD R · 2015 to 2019
$826k
Optimizing Critical Care for Patients with Acute Respiratory Failure: A Mixed-Methods StudyIK2HX003005 · VA · PORTLAND VA MEDICAL CENTER · PI VRANAS, KELLY C. · 2020 to 2023
–
HSRD VA IK2 HX003005NCI NIH HHS K07 CA190706NHLBI NIH HHS K12 HL133115
6 · The paper itself

Abstract

backgroundPalliative care is associated with improved survival and quality of life among patients with lung cancer; however, its influence on health-care utilization and quality of care is unclear. RESEARCH QUESTION: Is palliative care, and the setting in which it occurs, associated with health-care resource utilization and quality of care among patients with advanced lung cancer? STUDY DESIGN AND

methodsThis was a retrospective cohort study of 23,142 patients with stage IIIB/IV lung cancer in the Veterans Affairs HealthCare System between 2007 and 2013. Exposures included the receipt of specialist-delivered palliative care, and the setting of the initial palliative care encounter (inpatient or outpatient) received after cancer diagnosis. Primary outcomes included rates of ED visits, along with rates of hospitalization and odds of ICU admission within the last 30 days of life. Secondary outcomes included any health-care utilization (ED, hospital, or ICU) related to chemotherapy toxicity. We used propensity score methods to perform Poisson and logistic regression modeling.

resultsAmong the 23,142 patients, 57% received palliative care, and 36% of initial palliative care encounters were outpatient. Compared with no palliative care, initial palliative care encounter in the outpatient setting was associated with reduced rates of ED visits (adjusted incidence rate ratio [aIRR], 0.86; 95% CI, 0.77-0.96) and hospitalizations in the last 30 days of life (aIRR, 0.64; 95% CI, 0.59-0.70). Initial palliative care encounters in both inpatient (adjusted OR [aOR], 0.63; 95% CI, 0.53-0.75) and outpatient (aOR, 0.42; 95% CI, 0.35-0.52) settings were associated with reduced odds of ICU admission in the last 30 days of life. Palliative care was also associated with reduced health-care utilization related to chemotherapy toxicity (aOR, 0.88; 95% CI, 0.82-0.95).

interpretationPalliative care (particularly in outpatient settings) is associated with reduced health-care utilization at the end of life and may improve the quality of care among patients with advanced lung cancer. These findings support the role of palliative care as an important component of comprehensive cancer care and highlight the potential benefits of outpatient palliative care services.

Indexed as

Lung NeoplasmsPalliative CareQuality of LifeAgedComprehensive Health CareFemaleHome Care ServicesHospitalizationHumansMaleNeoplasm StagingPatient Acceptance of Health CareQuality of Health CareRetrospective StudiesTerminal CareUnited Statesend of lifelung cancerpalliative carequality of liferesource utilization

Identifiers

PMID32589949
PMCPMC7768936
OpenAlexW3036112641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.